Our findings further suggest that captopril (and possibly other ACE inhibitors) could provide a novel therapeutic target for the treatment of ADHD, particularly in males expressing the Predominantly Hyperactive/Impulsive Subtype of this disorder. The gene discussed is ACE; the disease is attention deficit-hyperactivity disorder.